Liminatus Pharma, Inc. (LIMN) - Latest Market Data

Price & Market Data

Price: $0.19

Daily Change: +$0.0054 / 2.84%

Daily Range: $0.183 - $0.195

Market Cap: $8,279,923

Daily Volume: 92,757

Performance Metrics

1 Week: 4.24%

1 Month: -20.54%

3 Months: -72.98%

6 Months: -89.34%

1 Year: -97.95%

YTD: -69.75%

Company Details

Employees: 1

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.

Selected stocks

CuriosityStream Inc. (CURI)

Apollo Commercial Real Estate Finance, Inc (ARI)

Grupo Aeroportuario del Sureste, S.A. de C.V. (ASR)